According to DataM Intelligence, the Glucagon-like Peptide-1 (GLP-1) Analogues Market is witnessing a transformative ...

Shared biological, psychological, and social pathways put patients at risk for both, whether obesity or depression occurs ...

The study also presented the first external validation and use in patients with early RA of six proposed screening strategies ...

C HICAGO -- People who died with systemic lupus erythematosus (SLE) were far more likely than car crash victims to have ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

The Hemorrhagic Stroke Treatment Market is projected to witness robust growth, expanding from USD 3.7 billion in 2025 to USD ...

CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory ...

The steady growth of the BCM market is fueled by multiple converging trends. Pharmaceutical and biotechnology companies are ...

The hidradenitis suppurativa market is poised for strong growth, driven by increasing disease awareness, earlier diagnosis, and expanding treatment access. Advances in biologic and targeted therapies, ...

Teen heir Johannes von Baumbach is the world’s youngest billionaire, inheriting a fortune from German pharma giant Boehringer ...

Market is projected to grow from US$ 3.97 billion in 2024 to US$ 4.92 billion by 2033, at a CAGR of 2.42%. Factors driving ...

Boehringer Ingelheim has announced that China's National Medical Products Administration (NMPA) has approved JASCAYD (nerandomilast) as an oral treatment option for idiopathic pulmonary ...